3UQ-23044-11293
3 vaccinations
3 coded responses
27 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 282 / NC
- Registered
- 2021-03-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-31
Registered in v-safe
-
2021-03-31
Dose 1 — Pfizer-BioNTech
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-09
- 2021-04-14
-
2021-04-21
Dose 2 — Pfizer-BioNTech
- 2021-04-21
-
2021-04-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-05-05
-
2021-05-12
Survey response — day 21, dose 2MedDRA: Ageusia, Hypogeusia — Feeling: GoodFree text: Sense of taste does seem reducedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-19
- 2021-05-26
- 2021-06-02
- 2021-07-21
- 2021-10-20
-
2021-12-29
Dose 3 — Pfizer-BioNTech
- 2022-04-21
-
2022-06-29
Survey response — 6 months, dose 3MedDRA: COVID-19, Cough, Sinus congestion, Vertigo — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I contracted Covid May 26, 2022 - Bad coughing - sinus congestion - vertigoMedDRA releases: 2024-11 · check-in free text available
-
2022-06-29
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-06-30
Call successfulNot applicable - Accidental Reporting
-
2022-12-29
Survey response — 12 months, dose 3MedDRA: COVID-19, Vertigo — Feeling: Good · Be unable to do your normal daily activitiesFree text: I am experiencing periodic vertigo, since contracting COVID May, 2022MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-31 | Pfizer-BioNTech | |
| 2 | 2021-04-21 | Pfizer-BioNTech | |
| 3 | 2021-12-29 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-06-29 | Successful 2022-06-30 |
Not applicable - Accidental Reporting |
Free text
Release 8 — day 21, dose 2
Symptoms: Sense of taste does seem reduced
Release 12 — 6 months, dose 3
Symptoms: I contracted Covid May 26, 2022 - Bad coughing - sinus congestion - vertigo
Release 12 — 12 months, dose 3
Symptoms: I am experiencing periodic vertigo, since contracting COVID May, 2022
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | ✓ | ✓ | ○ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Hypogeusia | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SD | Vertigo | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release